DecodeHealth, Author at Decode Health

7 06, 2024

AI in Pharma: Revolutionizing Biotechnology and Precision Medicine

DecodeHealth2024-06-07T09:06:27-05:00

This article is written in response to "AI in Pharma: The Growing Number of Pharmaceutical Use Cases" by Nick Wichert of High Alpha Innovation

AI in Pharma: Revolutionizing Biotechnology and Precision MedicineDecodeHealth2024-06-07T09:06:27-05:00

7 06, 2024

Advanced multivariate analysis to discover candidate RNA biomarkers to distinguish relapsing-remitting multiple sclerosis and neuromyelitis optica

DecodeHealth2024-06-07T09:04:06-05:00

2024 CMSC Conference Presentation

Advanced multivariate analysis to discover candidate RNA biomarkers to distinguish relapsing-remitting multiple sclerosis and neuromyelitis opticaDecodeHealth2024-06-07T09:04:06-05:00

7 06, 2024

Machine learning framework for multiple sclerosis risk stratification and healthcare cost prediction

DecodeHealth2024-06-07T09:01:24-05:00

2024 CMSC Conference Presentation

Machine learning framework for multiple sclerosis risk stratification and healthcare cost predictionDecodeHealth2024-06-07T09:01:24-05:00

7 06, 2024

Unique RNA expression profiles associated with plasma neurofilament light chain measurements in relapsing-remitting multiple sclerosis and neuromyelitis optica

DecodeHealth2024-06-07T09:04:25-05:00

2024 CMSC Conference Presentation

Unique RNA expression profiles associated with plasma neurofilament light chain measurements in relapsing-remitting multiple sclerosis and neuromyelitis opticaDecodeHealth2024-06-07T09:04:25-05:00

8 03, 2024

Decode Health Biomarker Discovery Platform Advances Findings in MS and NMO

DecodeHealth2024-03-27T13:53:07-05:00

Decode Health deployed its biomarker discovery platform, incorporating machine learning, to provide new insights into multiple sclerosis (MS) and neuromyelitis optica (NMO). The Decode platform identified disease-specific RNA biomarkers and connections between RNA expression [read more...]

Decode Health Biomarker Discovery Platform Advances Findings in MS and NMODecodeHealth2024-03-27T13:53:07-05:00

6 03, 2024

Development and evaluation of Total RNA sequencing quality controls for blood-based biomarker discovery

DecodeHealth2024-03-20T17:58:00-05:00

November 2023 – Poster Presentation

Development and evaluation of Total RNA sequencing quality controls for blood-based biomarker discoveryDecodeHealth2024-03-20T17:58:00-05:00

1 03, 2024

Inc. Recognizes Decode Health as a Top 100 Company in the Southeast

DecodeHealth2024-03-12T11:50:36-05:00

Inc., known for its insightful coverage of innovative businesses and start-up companies, acknowledges the fastest-growing private entities in the United States. Decode Health was recognized as one of Inc.’s top 100 companies of 2024, driving [read more...]

Inc. Recognizes Decode Health as a Top 100 Company in the SoutheastDecodeHealth2024-03-12T11:50:36-05:00

6 03, 2024

Application of an advanced data analytics platform leveraging artificial intelligence to identify RNA biomarkers

DecodeHealth2024-03-08T15:29:51-06:00

November 2023 – Poster Presentation

Application of an advanced data analytics platform leveraging artificial intelligence to identify RNA biomarkersDecodeHealth2024-03-08T15:29:51-06:00

6 03, 2024

Discovery of unique RNA profiles associated with plasma neurofilament light chain measurements in relapsing-remitting multiple sclerosis and neuromyelitis optica

DecodeHealth2024-03-08T15:29:26-06:00

October 2023 – Poster Presentation

Discovery of unique RNA profiles associated with plasma neurofilament light chain measurements in relapsing-remitting multiple sclerosis and neuromyelitis opticaDecodeHealth2024-03-08T15:29:26-06:00

6 03, 2024